Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue

被引:42
作者
Guttman, D [1 ]
Stern, Y [1 ]
Shpitzer, T [1 ]
Ulanovski, D [1 ]
Druzd, T [1 ]
Feinmesser, R [1 ]
机构
[1] Rabin Med Ctr, Dept Otorhinolaryngol, IL-49100 Petah Tiqwa, Israel
关键词
matrix; metalloproteinase; tongue; neovascularization; tumor; invasion; metastasis; basement membrane;
D O I
10.1016/j.oraloncology.2004.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Squamous cell carcinoma (SCC) of the tongue is characterized by an unpredictable course, ranging from relatively benign to a high degree of locally aggressive growth and metastasis. Treatment guidelines have been developed according to TNM stage, but they do not always accurately predict clinical outcome. The aim of the present study was to evaluate the expression of the matrix metalloproteinases (MMPs) that degrade the extracellular matrices, their inhibitors (TIMPs), and angiogenic factors (factor-8 and CD-34) in tumor cells and to correlate these findings with the clinicopathological features and patient outcome. Tissue specimens from 23 patients with primary SCC of the tongue were immunohistochemically stained for these markers. High expressions of MMP-9 and TIMP-1 were detected in 60.9% and 65.2% of the specimens, respectively. Tumor invasion to adjacent muscle, lymph node metastasis, and disease status at the end of follow-up were positively correlated with the microvesset count using the CD-34 marker, but not with high expression of MMP-9 or TIMP-1. Expression of MMP-9 and TIMP-1 fails to predict aggressiveness in SCC of the tongue. However, the degree of vascularization in tumor tissue is indicative of disease aggressiveness and might be used as a basis for patient selection for more intensive therapy. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:798 / 803
页数:6
相关论文
共 24 条
[1]  
[Anonymous], 1998, OTOLARYNGOLOGY HEAD
[2]   GROWTH-STIMULATION OF HUMAN KERATINOCYTES BY TISSUE INHIBITOR OF METALLOPROTEINASES [J].
BERTAUX, B ;
HORNEBECK, W ;
EISEN, AZ ;
DUBERTRET, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (04) :679-685
[3]   Changing views of the role of matrix metalloproteinases in metastasis [J].
Chambers, AF ;
Matrisian, LM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1260-1270
[4]   Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma [J].
Charous, SJ ;
Stricklin, GP ;
Nanney, LB ;
Netterville, JL ;
Burkey, BB .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (04) :271-278
[5]  
Fidler Isaiah J., 1997, P135
[6]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[7]  
GRAHAM CH, 1994, AM J PATHOL, V145, P510
[8]  
HOLLINGSWORTH HC, 1995, AM J PATHOL, V147, P33
[9]   Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer [J].
Ikebe, T ;
Shinohara, M ;
Takeuchi, H ;
Beppu, M ;
Kurahara, S ;
Nakamura, S ;
Shirasuna, K .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (04) :315-323
[10]  
Imren S, 1996, CANCER RES, V56, P2891